IGF2BP3 and neoplasm: These findings suggest that let-7g-5p post-transcriptionally inhibits IGF2BP3 through a direct binding mechanism, and loss of let-7g-5p in GBC tissues may be involved in IGF2BP3-mediated tumor progression.